Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Lukmanee Tradtrantip, Nithi Asavapanumas & Alan S. Verkman. (2020) Emerging therapeutic targets for neuromyelitis optica spectrum disorder. Expert Opinion on Therapeutic Targets 24:3, pages 219-229.
Read now
Read now
Jie Lin, Binbin Xue, Zhibo Chen, Xiaming Huang, Wanhui Pang, Weiwei Quan, Yuanyuan Huang, Xiang Li & Junhui Xia. (2017) Effects of early using azathioprine in the acute phase in neuromyelitis optica spectrum disorder. International Journal of Neuroscience 127:6, pages 508-515.
Read now
Read now
Graça Soveral & Angela Casini. (2017) Aquaporin modulators: a patent review (2010–2015). Expert Opinion on Therapeutic Patents 27:1, pages 49-62.
Read now
Read now
Articles from other publishers (17)
Natthapon Rattanathamsakul, Sasitorn Siritho, Shanthi Viswanathan, Fu Liong Hiew, Metha Apiwattanakul, Kevin Tan, Umapathi N. Thirugnanam, Tianrong Yeo, Amy M. L. Quek, Riwanti Estiasari, Rabani Remli, Seinn Mya Mya Aye, Ohnmar Ohnmar, Nghia T. T. Hoang & Paul M. Pasco. (2023) Facilities, selection, outcome measurement, and limitations of therapeutic plasma exchange for neuroimmunological disorders: The South East Asian survey study. Journal of Clinical Apheresis 38:4, pages 437-446.
Crossref
Crossref
Huijing Xu, Yushuang Gong, Yang Jiao, Jian Guo, Ling Zhao, Juechen Yang, Haibin Tong, Meiyan Sun & Miao Li. (2023) Inhibition of Neuromyelitis Optica Immunoglobulin G Binding to Aquaporin-4
by the Small Molecule Blocker Melanthioidine. Current Pharmaceutical Design 29:10, pages 793-802.
Crossref
Crossref
Nikita DharMritunjai KumarAshutosh TiwariRamanuj SamantaAjeet Singh BhadoriaS. VivekanandhanSudhir SaxenaNiraj Kumar. (2023) Comparison of clinico-radiological profile, optical coherence tomography parameters, and outcome in MOGAD and Neuromyelitis optica spectrum disorder subtypes: A prospective observational study. Journal of Neurosciences in Rural Practice 14, pages 239-251.
Crossref
Crossref
Jie Lin, Binbin Xue, Ruofan Zhu, Juyuan Pan, Jia Li, Yan Lin, Xiang Li & Junhui Xia. (2021) Intravenous immunoglobulin as the rescue treatment in NMOSD patients. Neurological Sciences 42:9, pages 3857-3863.
Crossref
Crossref
Peng Bai, Meini Zhang, Jun Yuan, Runxiu Zhu & Na Li. (2021) A comparison of the effects of rituximab versus other immunotherapies for MOG-IgG-associated central nervous system demyelination: A meta-analysis. Multiple Sclerosis and Related Disorders 53, pages 103044.
Crossref
Crossref
Jayne L. Chamberlain, Saif Huda, Daniel H. Whittam, Marcelo Matiello, B. Paul Morgan & Anu Jacob. (2019) Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review. Journal of Neurology 268:5, pages 1643-1664.
Crossref
Crossref
Tina S. Ipe, Erin K. Meyer, Kimberly W. Sanford, Sarita K. Joshi, Edward C. C. Wong & Jay S. Raval. (2020) Use of therapeutic plasma exchange for pediatric neurological diseases. Journal of Clinical Apheresis 36:1, pages 161-176.
Crossref
Crossref
Lukmanee Tradtrantip, Tianjiao Duan, Michael R. Yeaman & Alan S. Verkman. (2019) CD55 upregulation in astrocytes by statins as potential therapy for AQP4-IgG seropositive neuromyelitis optica. Journal of Neuroinflammation 16:1.
Crossref
Crossref
Laura Cacciaguerra, Alessandro Meani, Sarlota Mesaros, Marta Radaelli, Jacqueline Palace, Irena Dujmovic-Basuroski, Elisabetta Pagani, Vittorio Martinelli, Lucy Matthews, Jelena Drulovic, Maria Isabel Leite, Giancarlo Comi, Massimo Filippi & Maria A. Rocca. (2019) Brain and cord imaging features in neuromyelitis optica spectrum disorders. Annals of Neurology 85:3, pages 371-384.
Crossref
Crossref
S. Jarius, A.B. Wuthenow & B. Wildemann. (2018) The first Japanese report on neuromyelitis optica rediscovered: acute bilateral blindness, tetraparesis and respiratory insufficiency in a 35-year-old man (1891). Journal of the Neurological Sciences 395, pages 121-125.
Crossref
Crossref
Seyed Mohammad Baghbanian, Nasrin Asgari, Mohammad Ali Sahraian & Abdorreza Naser Moghadasi. (2018) A comparison of pediatric and adult neuromyelitis optica spectrum disorders: A review of clinical manifestation, diagnosis, and treatment. Journal of the Neurological Sciences 388, pages 222-231.
Crossref
Crossref
Dean M. Wingerchuk. (2018) Immune-Mediated Myelopathies. CONTINUUM: Lifelong Learning in Neurology 24:2, pages 497-522.
Crossref
Crossref
Yang Yang, Chun-juan Wang, Bao-jie Wang, Zi-ling Zeng & Shou-gang Guo. (2018) Comparison of efficacy and tolerability of azathioprine, mycophenolate mofetil, and lower dosages of rituximab among patients with neuromyelitis optica spectrum disorder. Journal of the Neurological Sciences 385, pages 192-197.
Crossref
Crossref
Simão Laranjeira, Mkael Symmonds, Jacqueline Palace, Stephen J. Payne & Piotr Orlowski. (2017) A mathematical model of cellular swelling in Neuromyelitis optica. Journal of Theoretical Biology 433, pages 39-48.
Crossref
Crossref
Allen D. DeSena. (2017) Immune-Mediated CNS Diseases: a Review. Current Physical Medicine and Rehabilitation Reports 5:3, pages 134-142.
Crossref
Crossref
H. Chen, W. Qiu, Q. Zhang, J. Wang, Z. Shi, J. Liu, Z. Lian, H. Feng, X. Miao & H. Zhou. (2016) Comparisons of the efficacy and tolerability of mycophenolate mofetil and azathioprine as treatments for neuromyelitis optica and neuromyelitis optica spectrum disorder. European Journal of Neurology 24:1, pages 219-226.
Crossref
Crossref
M.L. Maciel, A.T. Sa, A.F. Zimmermann, F.S. Neves, S.C.M.S. Fialho & I.A. Pereira. (2017) DOENÇA DO ESPECTRO DA NEUROMIELITE ÓPTICA COM ANTI‐AQUAPORINA‐4 ASSOCIADO A MORFEIA (ESCLERODERMIA LOCALIZADA). Revista Brasileira de Reumatologia 57, pages S264-S265.
Crossref
Crossref